Comparative Study of Sequential Dose Misoprostol and Trans-Cervical Extra Amniotic Iodine Saline for Second Trimester Medical Termination Of Pregnancy
Journal Title: International Journal of Medical Research Professionals - Year 2018, Vol 4, Issue 5
Abstract
Background: Second trimester termination of pregnancy is a controversial topic since long having many moral, emotional, social, technical and legal issues. Old methods are being increasingly replaced by prostaglandin analogues like PGE1, PGE2, PGF2 alpha etc. But there is need for more studies to establish their regime, efficacy, contraindications, complications and cost effectiveness. Objective: To compare acceptability, safety, efficacy, complications, induction-abortion interval and cost effectiveness of Misoprostol and transcervical extra amniotic Iodine saline method for mid trimester termination of pregnancy. Method: Sixty women with valid legal indication of termination of 13-20 weeks of pregnancy were randomized in 2 groups. In group A, 400 μg of Misoprostol was given vaginally every 3 hours for a maximum of 5 doses (FIGO Protocol). In group B, 150 ml of 0.17% of sterile Povidone Iodine saline was instilled extra-amniotically with transcervical Foley’s catheter. Incidence and indications of abortion, success rate, induction-abortion interval, complications and client satisfaction were studied and analyzed. Results: Most common indication of second trimester termination of pregnancy was eugenic cause (73.33%). The mean induction-abortion interval was 16.84 hours in Misoprostol group and 25.77 hours in Iodine saline catheter group. The rate of complete abortion at 48 hours was 76.66% for Misoprostol and 63.33 % for Iodine saline group. The average cost per procedure was lesser for Misoprostol group as compared to Iodine saline group. Rate of side-effects was more with Iodine saline (66.66%) as compared to Misoprostol (50.33%). Conclusion: Misoprostol is highly efficacious with shorter induction – abortion interval, lesser need for post-abortal evacuation, lesser side effects and complications, higher safety profile, better cost effectiveness and hence better overall client satisfaction but in conditions where Misoprostol or other prostaglandins are better avoided or not available, Iodine saline catheter method seems to be a time tested, cheap, easily available and equally effective method.
Authors and Affiliations
Pankhuri Goyal Busar, Bipin M Nayak, Seema Sharma
Keywords
Related Articles
- EP ID EP536631
- DOI 10.21276/ijmrp.2018.4.5.006
- Views 64
- Downloads 0
Knowledge and Practice of Secondary School Students Toward Malaria Prevention and Control in Baish City, Saudi Arabia
Background: Malaria has been documented since 1941 as a major health problem in Saudi Arabia. The majority of malaria cases were of the malignant type caused by P. falciparum. The group of patients who were more than 14...
The Study of Facial Index among Medical Students
Background: Craniofacial anthropometry, as an important part of anthropology and medicine, is used for the determination of the morphological characteristics of the head and face. Face shape depends on many factors, such...
Prevalence of Odontogenic Keratocyst in Kashmir Valley: A Retrospective Analysis Over 10 Years
Objective: This study aimed to assess the demographic characteristics of odontogenic keratocyst in a tertiary dental healthcare center in Kashmir valley. Materials and Methods: A retrospective analysis of data of 1460 ca...
Effectiveness of Intragastric Balloon Placement in Obese Patients
Background: Intra-gastric balloon (IB) placement is gaining popularity for weight reduction. Objective: To assess effectiveness, tolerability and safety of IB for management of obesity. Methods and Materials: We retrospe...
Adverse Drug Reactions of Tyrosine Kinase Inhibitors in the Treatment of Advanced Lung Cancer
Introduction: Erlotinib and gefitinib are the most commonly used epidermal growth factor receptor‑tyrosine kinase inhibitors (EGFR‑TKIs) in the treatment of EGFR mutant nonsmall cell lung cancer (NSCLC). Both erlotinib a...